Advanced search
Publication Cover
International Journal of Women's Health Volume 6, 2014 - Issue
Submit an article Journal homepage
279
Views
16
CrossRef citations to date
0
Altmetric
Review

Past, present, and future of hormonal therapy in recurrent endometrial cancer

Matthew J CarlsonDepartment of Obstetrics and Gynecology, University of Iowa, Iowa City, IA, USA
,
Kristina W ThielDepartment of Obstetrics and Gynecology, University of Iowa, Iowa City, IA, USA
&
Kimberly K LeslieDepartment of Obstetrics and Gynecology, University of Iowa, Iowa City, IA, USACorrespondence[email protected]
Pages 429-435 | Published online: 02 May 2014

Citations (16)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Payel Guha, Koushik Sen, Piyali Chowdhury & Dilip Mukherjee. (2023) Estrogen receptors as potential therapeutic target in endometrial cancer. Journal of Receptors and Signal Transduction 43:1, pages 19-26.
Read now
Dong Li, Juan Zhang, Lilong Wu, Xiaoming Yang, Zheng Chen & Jiangjing Yuan. (2021) Myelin and Lymphocyte Protein (MAL): A Novel Biomarker for Uterine Corpus Endometrial Carcinoma. Cancer Management and Research 13, pages 7311-7323.
Read now
Marta Caretto & Tommaso Simoncini. (2021) Progestin or anti-estrogen treatment for endometrial cancer: choosing the best option for selected patients. Gynecological Endocrinology 37:11, pages 959-960.
Read now

Articles from other publishers (13)

Yidong Ge, Ziqing Zhan, Meng Ye & Xiaofeng Jin. (2023) The crosstalk between ubiquitination and endocrine therapy. Journal of Molecular Medicine 101:5, pages 461-486.
Crossref
Adelina-Gabriela Niculescu & Alexandru Mihai Grumezescu. (2022) Novel Tumor-Targeting Nanoparticles for Cancer Treatment—A Review. International Journal of Molecular Sciences 23:9, pages 5253.
Crossref
Szidónia Farkas, Adrienn Szabó, Anita Emőke Hegyi, Bibiána Török, Csilla Lea Fazekas, Dávid Ernszt, Tamás Kovács & Dóra Zelena. (2022) Estradiol and Estrogen-like Alternative Therapies in Use: The Importance of the Selective and Non-Classical Actions. Biomedicines 10:4, pages 861.
Crossref
Amelia Barcellini, Marianna Roccio, Concetta Laliscia, Francesca Zanellini, Diana Pettinato, Francesca Valvo, Alfredo Mirandola, Ester Orlandi & Angiolo Gadducci. (2021) Endometrial Cancer: When Upfront Surgery Is Not an Option. Oncology 99:2, pages 65-71.
Crossref
I. M. Ordiyants, A. A. Kuular, A. A. Yamurzina & D. S. Novginov. (2020) Predicting the risk of malignisation of endometrial hyperplasia in reproductive age. Fundamental and Clinical Medicine 5:1, pages 57-63.
Crossref
Adriana C. Rodriguez, Zannel Blanchard, Kathryn A. Maurer & Jason Gertz. (2019) Estrogen Signaling in Endometrial Cancer: a Key Oncogenic Pathway with Several Open Questions. Hormones and Cancer 10:2-3, pages 51-63.
Crossref
Willem Jan van Weelden, Leon F. A. G. Massuger, Johanna M. A. Pijnenborg & Andrea Romano. (2019) Anti-estrogen Treatment in Endometrial Cancer: A Systematic Review. Frontiers in Oncology 9.
Crossref
Joseph F. Peevey, Brandon-Luke L. Seagle, Kruti P. Maniar & J. Julie Kim. (2017) Association of body mass index with ER, PR and 14-3-3σ expression in tumor and stroma of type I and type II endometrial carcinoma. Oncotarget 8:26, pages 42548-42559.
Crossref
Soheila Aminimoghaddam, Ghazal Kamyabi, Fariba Yarandi & Soghra Zarei. (2017) Investigating the Association of Lower Uterine Segment Involvement with Deep Myometrial Invasion in Endometrial Adenocarcinoma. Journal of Obstetrics, Gynecology and Cancer Research 2:2, pages 0-0.
Crossref
Amber A. Bokhari, Laura R. Lee, Dewayne Raboteau, Jane Turbov, Isabel V. Rodriguez, John Wesley Pike, Chad A. Hamilton, George Larry Maxwell, Gustavo C. Rodriguez & Viqar Syed. (2016) Progesterone potentiates the growth inhibitory effects of calcitriol in endometrial cancer via suppression of CYP24A1. Oncotarget 7:47, pages 77576-77590.
Crossref
Ingvild Løberg Tangen, Therese Bredholt Onyango, Reidun Kopperud, Anna Berg, Mari K. Halle, Anne M. Øyan, Henrica M.J. Werner, Jone Trovik, Karl Henning Kalland, Helga B. Salvesen & Camilla Krakstad. (2016) Androgen receptor as potential therapeutic target in metastatic endometrial cancer. Oncotarget 7:31, pages 49289-49298.
Crossref
Ting-Yu Lin, Fang-Ju Wu, Chia-Lin Chang, Zhongyou Li & Ching-Wei Luo. (2016) NMU signaling promotes endometrial cancer cell progression by modulating adhesion signaling. Oncotarget 7:9, pages 10228-10242.
Crossref
Lev M. Berstein. 2015. Resistance to Aromatase Inhibitors in Breast Cancer. Resistance to Aromatase Inhibitors in Breast Cancer 261 285 .

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.